Specific GABAA agonists and partial agonists

Chemical Record

Volumn 2, Issue 6, 2002, Pages 419-430

  Krogsgaard Larsen, Povl ^a   Frølund, Bente ^a   Liljefors, Tommy ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

4 PIOL; Agonist; Functional selectivity; GABAA receptor; Muscimol; Partial agonist; THIP

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; 4,5,6,7-TETRAHYDROISOXAZOLO(5,4-C)PYRIDIN-3-OL; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; GABOXADOL; ISOXAZOLE DERIVATIVE; STEROID;

CHEMISTRY; DRUG POTENTIATION; HUMAN; METABOLISM; NERVOUS SYSTEM; REVIEW;

BENZODIAZEPINES; GABA AGONISTS; HUMANS; ISOXAZOLES; NERVOUS SYSTEM; NEUROTRANSMITTER AGENTS; RECEPTORS, GABA-A; STEROIDS;

EID: 3142590951     PISSN: 15278999     EISSN: 15280691     Source Type: Journal    
DOI: 10.1002/tcr.10040     Document Type: Article

References (70)

1. Olsen, R.W.; Venter, J.C. (eds). Benzodiazepine/GABA receptors and chloride channels: structural and functional properties. New York: John Wiley & Sons; 1986.
2. A/benzodiazepine receptor as a target for psychoactive drugs. Heidelberg: Springer; 1996.
3. B Receptors in mammalian function. Chichester: John Wiley & Sons; 1990.
4. Krogsgaard-Larsen, P.; Frolund, B.; Kristiansen, U.; Frydenvang, K.; Ebert, B. Eur J Pharm Sci 1997, 5, 355.
5. Egebjerg, J; Schousboe, A.; Krogsgaard-Larsen, P. Glutamate and GABA receptors and transporters: structure, function and pharmacology. London: Taylor & Francis; 2002.
6. Wheal, H.; Thomson, A. (eds). Excitatory amino acids and synaptic transmission. London: Academic Press; 1995.
7. Monaghan, D.T.; Wenthold, R.J. The ionotropic glutamate receptors. Totowa, NJ: Humana Press; 1997.
8. Walton, M.K.; Schaffner, A.E.; Barker, J.L. J Neurosci 1993, 13, 2068.
9. Roberts, E. Neurochem Res 1991, 16, 409.
10. Kardos, J.; Elster, L.; Damgaard, I.; Krogsgaard-Larsen, P.; Schousboe, A. J Neurosci Res 1994, 39, 646.
11. Ong, J.; Kerr, D.I.B. Life Sci 1990, 46, 1489.
12. Tanaka, C.; Bowery, N.G. GABA: Receptors, transporters and metabolism. Basel: Birkhäuser; 1996.
13. Edvinsson, L.; Larsson, B.; Skarby, T. Brain Res 1980, 185, 445.
14. Roland, P.E.; Friberg, L. J Cereb Blood Flow Metab 1988, 8, 314.
15. Rorsman, P.; Berggren, P.-O.; Bokvist, K.; Ericson, H.; Möhler, H.; Östenson, C.-G.; Smith, P.A. Nature 1989, 341, 233.
16. Caspary, D.M.; Raza, A.; Lawhorn Armour, B.A.; Pippin, J.; Arneric, S.P. J Neurosci 1990, 10, 2363.
17. Curtis, D.R.; Duggan, A.W.; Felix, D.; Johnston, G.A.R. Nature 1970, 226, 1222.
18. Johnston, G.A.R.; Beart, P.M.; Curtis, D.R.; Game, C.J.A.; McCulloch, R.M.; MacLachlan, R.M. Nature (New Biol) 1972, 240, 219.
19. Krogsgaard-Larsen, P.; Johnston, G.A.R.; Lodge, D.; Curtis, D.R. Nature 1977, 268, 53.
20. Krogsgaard-Larsen, P.; Snowman, A.; Lummis, S.C.; Olsen, R.W. J Neurochem 1981, 37, 401.
21. Bowery, N.G.; Hill, D.R.; Hudson, A.L.; Doble, A.; Middlemiss, D.N.; Shaw, J.;Turnbull, M. Nature 1980, 283, 92.
22. Martin, S.C.; Russek, S.J.; Farb, D.H. Mol Cell Neurosci 1999, 13, 180.
23. Möhler, H.; Fritschy, J.-M. Trends Pharmacol Sci 1999, 20, 87.
24. Möhler, H.; Okada, T. Science 1977, 198, 849.
25. Squires, R.F.; Braestrup, C. Nature 1977, 266, 732.
26. Johnston, G.A.R. Pharmacol Ther 1996, 69, 173.
27. Murata, Y.; Woodward, R.M.; Miledi, R.; Overman, L.E. Bioorg Med Chem Lett 1996, 6, 2073.
28. Cutting, G.R.; Lu, L.; O'Hara, B.E; Kasch, L.M.; Montrose-Rafizaheh, C.; Donovan, D.M.; Shimada, S.; Antonorakis, S.E.; Guggino, W.B.; Uhl, G.R.; Kazazian, H.H. Proc Natl Acad Sci USA, 1991, 88, 2673.
29. Stephenson, F.A.; Turner, A.J. (eds). Amino acid neurotransmission. London: Portland Press; 1998.
30. Boue-Grabot, E.; Roudbaraki, M.; Tramu, G.; Block, B.; Garret, M. J Neurochem 1998, 70, 899.
31. Sieghart, W. Pharmacol Rev 1995, 47, 181.
32. Whiting, P.J. Neurochem Int 1999, 34, 387.
33. Smith, G.B.; Olsen, R.W. Trends Pharmacol Sci 1995, 16, 162.
34. Hunkeler, W.; Möhler, H.; Fieri, L; Pole, P.; Bonetti, E.P.; Cumin, R.; Schaffner, R.; Haefely, W. Nature 1981, 290, 514.
35. Harrison, N.L.; Simmonds, M.A. Brain Res 1984, 323, 287.
36. Ong, J.; Kerr, D.I.B.; Johnston, G.A.R. Neurosci Lett 1987, 82, 101.
37. Gasior, M.; Carter, R.B.; Witkin, J.M. Trends Pharmacol Sci 1999, 20, 107.
38. Williams, M.; Kowaluk, E.A.; Arneric, S.P. J Med Chem 1999, 42, 1481.
39. Krogsgaard-Larsen, P.; Frolund, B.; Jorgensen, ES.; Schousboe, A. J Med Chem 1994, 37, 2489.
40. Krogsgaard-Larsen, P.; Hjeds, H.; Curtis, D.R.; Lodge, D.; Johnston, G.A.R. J Neurochem 1979, 32, 1717.
41. Krogsgaard-Larsen, P.; Nielsen, L.; Falch, E.; Curtis, D.R. J Med Chem 1986, 28, 1612.
42. Krogsgaard-Larsen, P.; Johnston, G.A.R. J Neurochem 1975, 25, 797.
43. Krogsgaard-Larsen, P.; Mikkelsen, H.; Jacobsen, P.; Falch, E.; Curtis, D.R.; Peet, M.J.; Leah, J.D. J Med Chem 1983, 26, 895.
44. Brehm, L.; Eben, B.; Kristiansen, U.; Wafford, K.A.; Kemp, J.A.; Krogsgaard-Larsen, P. Eur J Med Chem 1997, 32, 357.
45. Johnston, G.A.R.; Krogsgaard-Larsen, P.; Stephanson, A. Nature 1975, 258, 627.
46. Schousboe, A.; Thorbek, P.; Hertz, L.; Krogsgaard-Larsen, P. J Neurochem 1979, 33, 181.
47. Krogsgaard-Larsen, P.; Falch, E.; Schousboe, A.; Curtis, D.R.; Lodge, D. J Neurochem 1980, 34, 756.
48. Kehler, J.; Stensbol, T.B.; Krogsgaard-Larsen, P. Bioorg Med Chem Lett 1999, 9, 811.
49. Maksay, G. Mol Pharmacol 1994, 46, 386.
50. Krogsgaard-Larsen, P.; Hjeds, H.; Falch, E.; Jorgensen, F.S.; Nielsen, L. Adv Drug Res 1988, 17, 381.
51. Byberg, J.R.; Labouta, I.M.; Falch, E.; Hjeds, H.; Krogsgaard-Larsen, P.; Curtis, D.R.; Gynther, B.D. Drug Des Delivery 1987, 1, 261.
52. Kristiansen, U.; Lambert, J.D.C.; Falch, E.; Krogsgaard-Larsen, P. Br J Pharmacol 1991, 104, 85.
53. Frolund, B.; Kristiansen, U.; Brehm, L.; Hansen, A.B.; Krogsgaard-Larsen, P.; Falch, E. J Med Chem 1995, 38, 3287.
54. Rabe, H.; Picard, R.; Uusi-Oukari, M.; Hevers, W; Luddens, H.; Korpi, E.R. Eur J Pharmacol 2000, 409, 233.
55. Krogsgaard-Larsen, P.; Johnston, G.A.R. J Neurochem 1978, 30, 1377.
56. Haefliger, W.; Révész, L.; Maurer, R.; Römer, D.; Büscher, H.-H. Eur J Med Chem - Chim Ther 1984, 19, 149.
57. Frolund, B.; Tagmose, L.; Liljefors, T.; Stensbol, T.B.; Engblom, C.; Kristiansen, U.; Krogsgaard-Larsen, P. J Med Chem 2000, 43, 4930.
58. Westh-Hansen, S.E.; Wut, M.R.; Dekermendjian, K.; Liljefors, T.; Rasmussen, P.B.; Nielsen, M. NeuroReport 1999, 10, 2417.
59. Frolund, B.; Jorgensen, A.T.; Tagmose, L.; Stensbol, T.B.; Vestergaard, H.T.; Engblom, C.; Kristiansen, U.; Sanchez, C.; Krogsgaard-Larsen, P.; Liljefors, T. J Med Chem 2002, 45, 2454.
60. Unwin, N. Nature 1995, 373, 37.
61. [6l] DeFeudis, F.V. Drug News Perspect 1989, 2, 172.
62. Zorn, S.H.; Enna, S.J. Neuropharmacology 1987, 26, 433.
63. Hoehn-Saric, R. Psychopharmacology 1983, 80, 338.
64. Wafford, K.A.; Thompson, S.A.; Thomas, D.; Sikela, J.; Wilcox, A.S.; Whiting, P.J. Mol Pharmacol 1996, 50, 670.
65. Rudolph, U.; Crestani, E; Benke, D.; Brunig, I.; Benson, J.A.; Fritschy, J.M.; Martin, J.R.; Bluethmann, H.; Mohler, H. Nature 1999, 401, 796.
66. Landolt, H.P.; Gillin, J.C. CNS Drugs 2000, 13, 185.
67. Lancel, M.; Cronlein, T.A.; Faulhaber, J. Neuropsychopharmacology 1996, 15, 63.
68. Lancel, M.; Faulhaber, J. NeuroReport 1996, 7, 2241.
69. Lancel, M.; Wetter, T.C.; Steiger, A.; Mathias, S. Am J Physiol Endocrinol Metab 2001, 281, E130.
70. Lancel, M.; Faulhaber, J.; Deisz, R.A. Br J Pharmacol 1998, 123, 1471.